Alzheimer's Disease

Alzheimer's disease impacts a person's memory and their ability to perform daily tasks. If you
or someone you know has mild to moderate Alzheimer's, you may be eligible to participate in a new clinical research study.

We are currently assessing the safety and efficacy of an investigational medication to slow or halt the progression of Alzheimer's disease. To be eligible for the study, participants must:

  • Be 55 years or older and generally healthy.
  • Have mild to moderate Alzheimer's disease.
  • Have a reliable caregiver who can assist during the study.

Participants can continue taking their current Alzheimer's medication.

For more information please contact:

Jaime Latorre, M.D.
Email: jlatorre@drkudrow.com

2001 Santa Monica Blvd. Suite 880W, Santa Monica, CA 90404
Tel: (310) 315-1456 | Fax: (310) 315-1486

Back to current trials